A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes have?
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes has 150 citations in the OpenAlex counts ScholarIQ stores.
When was A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes published?
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes has 2005 year in the ScholarIQ index.
What is the open-access status of A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes has gold oa status in the ScholarIQ index.
What is the DOI of A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?
The DOI for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is on the source record.
What is the PMID of A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?
The PMID for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is on the source record.
What is the OpenAlex record for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?
The OpenAlex for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is on the source record.